<?xml version="1.0" encoding="UTF-8"?>
<p id="para70">The immune preparedness of children to any novel pathogens, including, SARS-CoV-2 might be based on several factors. First, in the early phases of infection, natural antibodies
 <xref rid="bib8" ref-type="bibr">
  <sup>8</sup>
 </xref> play a most important role. Natural antibodies, mostly of IgM isotype and generated independently of previous antigen encounters, have a broad reactivity and a variable affinity. They contain the infection during the 2 weeks necessary for production of high-affinity antibodies and MBCs
 <xref rid="bib9" ref-type="bibr">
  <sup>9</sup>
 </xref> that will clear the virus and prevent reinfection. High-affinity antibodies are expressed by switched MBCs. In humans, natural antibodies are produced by innate or IgM MBCs, a population of MBCs that is generated independently of the germinal centres and is most abundant in children.
 <xref rid="bib10" ref-type="bibr">10</xref>, 
 <xref rid="bib5" ref-type="bibr">5</xref> From this population of B cells, sorted from the blood of young adults never exposed to avian influenza virus, we have cloned human antibodies able to neutralise antigenically diverse H1, H2, H5, H6, H8, and H9 influenza subtypes.
 <xref rid="bib11" ref-type="bibr">
  <sup>11</sup>
 </xref> Thus, innate or IgM MBCs can bind many different unknown microorganisms.
</p>
